Eisai Co., Ltd
Attack Intelligence
Eisai Co., Ltd was compromised in a ransomware attack attributed to atomsilo in June 2023. The organization, operating in the Healthcare sector in Japan, was added to the group's data leak site as part of an extortion campaign.
atomsilo operates as a financially motivated ransomware-as-a-service (RaaS) operation, exfiltrating sensitive data and threatening public disclosure to pressure victims into paying ransom demands.
[AI generated] Eisai Co., Ltd. is a Japanese multinational pharmaceutical company headquartered in Tokyo. Established in 1941, it's one of the leading firms in the field of neurology and oncology. Eisai produces several drugs used globally such as Aricept for Alzheimer's disease and Halaven for breast cancer. Aside from drug creation, Eisai also engages in global health initiatives.